-
Mashup Score: 1American Society on Aging - 3 year(s) ago
ASA is the go-to source to cultivate leadership, advance knowledge and strengthen the skills of our members and others who work with and on behalf of older adults.
Source: American Society on AgingCategories: Geriatrics, Latest HeadlinesTweet
-
Mashup Score: 2Can the Charlson Comorbidity Index be used to predict the ASA grade in patients undergoing spine surgery? | European Spine Journal - 3 year(s) ago
BackgroundThe American Society of Anaesthesiologists’ Physical Status Score (ASA) is a key variable in predictor models of surgical outcome and “appropriate use criteria”. However, at the time when such tools are being used in decision-making, the ASA rating is typically unknown.
Source: www.europeanspinejournal.orgCategories: Latest Headlines, RheumatologyTweet-
Can the #CharlsonComorbidityIndex be used to predict the #ASA grade in patients undergoing #spine #surgery? https://t.co/ZWjK5YyDQJ https://t.co/5Og124JpBA
-
-
Mashup Score: 1High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients - 4 year(s) ago
Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (N-ERD) consists of chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma, and NSAID intolerance. Acetylsalicylic acid treatment after desensitization (ATAD) is a treatment option for uncontrolled N-ERD.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! High Discontinuation Rates of #Peroral #ASA Treatment for #CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients https://t.co/Ys5wMLVV1I https://t.co/gV6kVHuRUw
-
-
Mashup Score: 0Effect of LTRA In L-ASA Challenge For Aspirin Exacerbated Respiratory Disease Diagnosis - 4 year(s) ago
Aspirin-exacerbated respiratory disease (AERD), consists of asthma, chronic rhinosinusitis with polyps and hypersensitivity to Aspirin and/or non-steroidal anti-inflammatory drugs (NSAIDs). Nasal Lysine Aspirin Challenge is an effective tool for the diagnosis of hypersensitivity to aspirin and/or NSAIDs in patients with AERD. However, there is not a unified international consensus version to…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Effect of #LTRA In #L- #ASA #Challenge For #Aspirin #Exacerbated #Respiratory #Disease #Diagnosis https://t.co/TLCF35XhQu https://t.co/sjLhRReJ1y
-
-
Mashup Score: 0Can the Charlson Comorbidity Index be used to predict the ASA grade in patients undergoing spine surgery? | European Spine Journal - 4 year(s) ago
BackgroundThe American Society of Anaesthesiologists’ Physical Status Score (ASA) is a key variable in predictor models of surgical outcome and “appropriate use criteria”. However, at the time when such tools are being used in decision-making, the ASA rating is typically unknown.
Source: www.europeanspinejournal.orgCategories: Latest Headlines, RheumatologyTweet-
Can the Charlson Comorbidity Index be used to predict the #ASA grade in patients undergoing #spine #surgery? https://t.co/ZWjK5YyDQJ https://t.co/lYdpVL31aA
-
-
Mashup Score: 0High discontinuation rates of peroral ASA treatment for CRSwNP. A real-world multi-center study of 171 N-ERD patients - 4 year(s) ago
Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (N-ERD) consists of chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma and NSAID intolerance. Acetylsalicylic acid (ASA) treatment after desensitization (ATAD) is a treatment option for uncontrolled N-ERD.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! High discontinuation rates of #peroral #ASA treatment for #CRSwNP. A real-world multi-center study of 171 N-ERD patients https://t.co/TI9PeIK6jK https://t.co/WxEih5e8OR
-
-
Mashup Score: 0Home teeth whitening company found in breach of advertising regulations – Dentistry Online - 4 year(s) ago
A home teeth whitening kit company has come under fire for breaching a number of advertising codes on social media app, Snapchat.
Source: Dentistry.co.ukCategories: Dental, Latest HeadlinesTweet-
Home teeth whitening company ‘misleadingly exaggerated’ with advert ⬇️ https://t.co/NWjnMcoazD #advertisingstandards #asa #snapchat #socialmedia #toothwhitening #teethwhitening #dentistryonline #dentistry #dentalnews #dentistrynews #dentalnewsuk https://t.co/x3AaiYlobK
-
-
Mashup Score: 3
Compared with aspirin monotherapy, P2Y12 inhibitor monotherapy is associated with a risk reduction for myocardial infarction and a comparable risk of stroke in the setting of secondary prevention. The benefit of P2Y12 inhibitor monotherapy is of debatable clinical relevance, in view of the high number needed to treat to prevent a myocardial infarction and the absence of any effect on all-cause…
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
#P2Y12i or #ASA for secondary prev in pts w established atherosclerosis: systematic review/meta-analysis Reduction in risk of #MI amongst pts who received P2Y12 inhibitor c/w those who received aspirin (OR 0.81 [95% CI 0.66-0.99]), w a NNT=244 pts https://t.co/qMX8nvgmvl
-
-
Mashup Score: 0Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019 | Circulation - 4 year(s) ago
Background: Recent American College of Cardiology/American Heart Association Primary Prevention Guidelines recommended considering low-dose aspirin therapy only among adults 40 to 70 years of age w…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
CAC may be superior to the Pooled Cohort Equations to inform allocation of #ASA in primary prevention #MESA https://t.co/r30EyAKwPE #AHAJournals @michael23ca @CiccaroneCenter @hopkinsheart https://t.co/yEny6HUNAl
-
-
Mashup Score: 1
Compared with aspirin monotherapy, P2Y12 inhibitor monotherapy is associated with a risk reduction for myocardial infarction and a comparable risk of stroke in the setting of secondary prevention. The benefit of P2Y12 inhibitor monotherapy is of debatable clinical relevance, in view of the high number needed to treat to prevent a myocardial infarction and the absence of any effect on all-cause…
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
C/w #ASA monotherapy, #P2Y12i mono assoc w risk reduction for #AMI & #stroke in setting of 2° prevention. The benefit of P2Y12i monotherapy is of debatable clinical relevance, in view of the high number NNT to prevent an MI & absence of effect mortality. https://t.co/T5DR5ya9bO
-
Join us on the Exploring Male Caregiving for People Living with Dementia webinar! #ASA #HappeningNow https://t.co/0QPF7bZhFC